4AB:FRA
AbbVie Common Stock
€220.80
arrow_downward
-1.65%(-3.70) 1D
Sep 4, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€222.70
High
€222.70
Low
€220.80
Mkt. cap
453.19B
Avg. vol.
64.00
Volume
65.00
52-wk high
€234.40
52-wk low
€167.55
No. of employees
57K
Open
€222.70
High
€222.70
Low
€220.80
Mkt. cap
453.19B
Avg. vol.
64.00
Volume
65.00
52-wk high
€234.40
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
Simply Wall Street
·
5 hours ago
AbbVie (ABBV) Stock Looks Below Fair Value Despite Mixed Valuation Signals
AD HOC NEWS
·
11 hours ago
AbbVie Inc. stock holds near highs as Apogee deal and guidance support sentiment
TechStock²
·
1 day ago
AbbVie Closes $10.9 Billion Apogee Deal; Earnings Payoff Starts in 2032
The Globe and Mail
·
1 day ago
Scotiabank Remains a Buy on AbbVie (ABBV)
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com